Anacetrapib

From Citizendium
Revision as of 08:31, 22 November 2010 by imported>Daniel Mietchen ({{subpages}})
Jump to navigation Jump to search
This article is a stub and thus not approved.
 Main Article
 Discussion
Related Articles  [?]
Bibliography  [?]
External Links  [?]
Citable Version  [?]
 
https://en.citizendium.org/wiki/index.php?title=Anacetrapib&printable=yes
This editable Main Article is under development and subject to a disclaimer.

In health care, anacetrapib (anacet'rapib) is an oxazolidinone medication that is a cholesteryl ester transfer protein inhibitor that raises HDL cholesterol and reduces LDL cholesterol.[1]

Anacetrapib is related to torcetrapib.[2]

References

  1. ↑ Anonymous (2024), Anacetrapib (English). Medical Subject Headings. U.S. National Library of Medicine.
  2. ↑ Cannon CP, Shah S, Dansky HM, Davidson M, Brinton EA, Gotto AM et al. (2010). "Safety of Anacetrapib in Patients with or at High Risk for Coronary Heart Disease.". N Engl J Med. DOI:10.1056/NEJMoa1009744. PMID 21082868. Research Blogging.
Retrieved from "https://citizendium.org/wiki/index.php?title=Anacetrapib&oldid=812467"